AUBRI ASHBACHER: Open Payments
NPI 1528677200 · CARTHAGE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 20 payments from 12 companies in 2025. Trend: 2023 $595 · 2024 $688 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 3 | $50 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Viatris Specialty LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: BREZTRI, JARDIANCE, NURTEC ODT, MOUNJARO, CAPLYTA, YUPELRI, GVOKE HYPOPEN, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
